FDA approves first daily pill to drastically lower cholesterol levels
Summary
The FDA has approved a new daily pill called Lipfendra from Merck that significantly lowers bad cholesterol (LDL-C) in adults. The pill works by blocking a protein called PCSK9, which helps reduce cholesterol levels effectively.Key Facts
- Lipfendra is the first daily pill that directly lowers LDL cholesterol by targeting PCSK9 proteins.
- The FDA has officially approved Lipfendra for use in adults.
- The medication comes from the pharmaceutical company Merck.
- It offers similar benefits to other strong cholesterol-lowering treatments already available.
- Lowering LDL cholesterol helps reduce the risk of heart disease.
- Lipfendra is taken once every day.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
